Febuxostat

CHEMBL1164729 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

316.4 g/mol

LogP

3.9

Phase

4

This medication blocks the enzyme xanthine oxidase, which produces uric acid, reducing blood uric acid levels and preventing gout attacks. It is used when patients cannot tolerate allopurinol or when allopurinol is insufficient.

Moleküler Ağırlık

316,4000 g/mol

LogP

3,90

TPSA

111,00 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Cardiovascular Disease Parkinson's Disease Chronic Kidney Disease Non-Alcoholic Fatty Liver Disease Obesity Type 2 Diabetes Hypertension Gout

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

Cc1nc(-c2ccc(OCC(C)C)c(C#N)c2)sc1C(=O)O

InChI

InChI=1S/C16H16N2O3S/c1-9(2)8-21-13-5-4-11(6-12(13)7-17)15-18-10(3)14(22-15)16(19)20/h4-6,9H,8H2,1-3H3,(H,19,20)

Molecular Formula

C16H16N2O3S

HBD / HBA

1 / 6

Döndürülebilir Bağlar

5

Ağır Atomlar

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This medication blocks the enzyme xanthine oxidase, which produces uric acid, reducing blood uric acid levels and preventing gout attacks. It is used when patients cannot tolerate allopurinol or when allopurinol is insufficient.

Yes, Febuxostat is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1164729. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 134018. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Febuxostat PillFYI'da

Yapı

Hızlı Veriler

Formül: C16H16N2O3S
Eş Anlamlılar: 1

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.